Patents Assigned to UAF Technologies and Research, LLC
  • Patent number: 6984654
    Abstract: A pharmaceutical composition that inhibits the growth of tumors and cancers in mammals and can be used to treat viral infections that comprises a fungicide is disclosed. The particular fungicide used is a benzimidazole derivative having the formula: wherein R is selected from the group consisting of H, carboxyl (—CO2H), hydroxyl, amino or esters (—CO2R?) wherein R? is selected from the group consisting of alkoxy, haloalkyl, alkenyl, and cycloalkyl wherein the alkyl groups have from 1–8 carbons or CH3CH2(OCH2CH2)n— or CH3CH2CH2(OCH2CH2CH2)n— or (CH3)2CH—(OCH(CH3)CH2)n— wherein n is from 1–3, the pharmaceutically acceptable salts thereof, or mixtures thereof.
    Type: Grant
    Filed: January 13, 2003
    Date of Patent: January 10, 2006
    Assignee: UAF Technologies and Research, LLC
    Inventor: James Berger Camden
  • Publication number: 20050288349
    Abstract: A pharmaceutical composition that inhibits the growth of tumors and cancers in mammals and can be used to treat viral infections that comprises a fungicide is disclosed. The particular fungicide used is a benzimidazole derivative having the formula: wherein R is selected from the group consisting of H, carboxyl (—CO2H), hydroxyl, amino or esters (—CO2R?) wherein R? is selected from the group consisting of alkoxy, haloalkyl, alkenyl, and cycloalkyl wherein the alkyl groups have from 1-8 carbons or CH3CH2(OCH2CH2)n— or CH3CH2CH2(OCH2CH2CH2)n— or (CH3)2CH—(OCH(CH3)CH2)n— wherein n is from 1-3, the pharmaceutically acceptable salts thereof, or mixtures thereof.
    Type: Application
    Filed: August 26, 2005
    Publication date: December 29, 2005
    Applicant: UAF Technologies and Research, LLC
    Inventor: James Camden
  • Publication number: 20050288348
    Abstract: Benzimidazole derivatives and salts and prodrugs thereof are disclosed, together with methods for the treatment of cancers or viral infections in warm blooded animals by administration of these compounds. Such compounds may be used in combination with a chemotherapeutic agent and/or a potentiator.
    Type: Application
    Filed: August 16, 2005
    Publication date: December 29, 2005
    Applicant: UAF Technologies and Research, LLC
    Inventors: James Camden, James Quada, Joseph Agyin
  • Publication number: 20050192328
    Abstract: Benzimidazole derivatives and salts and prodrugs thereof are disclosed, together with methods for the treatment of cancers or viral infections in warm blooded animals by administration of these compounds. Such compounds may be used in combination with a chemotherapeutic agent and/or a potentiator.
    Type: Application
    Filed: October 21, 2004
    Publication date: September 1, 2005
    Applicant: UAF Technologies and Research, LLC
    Inventors: James Camden, James Quada, Joseph Agyin
  • Patent number: 6930121
    Abstract: Benzimidazole derivatives and salts and prodrugs thereof are disclosed, together with methods for the treatment of cancers or viral infections in warm blooded animals by administration of these compounds. Such compounds may be used in combination with a chemotherapeutic agent and/or a potentiator.
    Type: Grant
    Filed: October 8, 2002
    Date of Patent: August 16, 2005
    Assignee: UAF Technologies and Research, LLC
    Inventors: James Berger Camden, James C. Quada, Jr., Joseph K. Agyin
  • Patent number: 6916836
    Abstract: Benzimidazole derivatives and salts and prodrugs thereof are disclosed, together with methods for the treatment of cancers or viral infections in warm blooded animals by administration of these compounds. Such compounds may be used in combination with a chemotherapeutic agent and/or a potentiator.
    Type: Grant
    Filed: August 5, 2003
    Date of Patent: July 12, 2005
    Assignee: UAF Technologies and Research, LLC
    Inventors: James Berger Camden, James C. Quada, Jr., Joseph K. Agyin
  • Patent number: 6906091
    Abstract: Methods of treating and inhibiting cancer in animals by administering a therapeutically effective amount of a pharmaceutical composition having benzimidazole of the general formula: wherein X is hydrogen, halogen, alkyl of less than 7 carbon atoms or alkoxy of less than 7 carbon atoms; n is a positive integer of less than 4; Y is hydrogen, chlorine, oxychloro, nitro, methyl or ethyl; and R is hydrogen, or an alkyl group of from 1 to 8 carbon atoms and R2 is NHCOOR1 wherein R1 is aliphatic hydrocarbon of less than 7 carbon atoms, and preferably an alkyl group of less than 7 carbon atoms and pharmaceutically acceptable derivatives alone, or in combination, or in conduction with other therapeutic agents such as other cancer inhibiting compounds, and operative combinations thereof.
    Type: Grant
    Filed: July 18, 2002
    Date of Patent: June 14, 2005
    Assignee: UAF Technologies and Research, LLC
    Inventor: James Berger Camden
  • Patent number: 6900235
    Abstract: Benzimidazole derivatives and salts and prodrugs thereof are disclosed, together with methods for the treatment of cancers or viral infections in warm blooded animals by administration of these compounds. Such compounds may be used in combination with a chemotherapeutic agent and/or a potentiator.
    Type: Grant
    Filed: September 29, 2000
    Date of Patent: May 31, 2005
    Assignee: UAF Technologies and Research, LLC
    Inventors: Joseph K. Agyin, James C. Quada, Jr., James Berger Camden
  • Patent number: 6864275
    Abstract: Benzimidazole derivatives and salts and prodrugs thereof are disclosed, together with methods for the treatment of cancers or viral infections in warm blooded animals by administration of these compounds. Such compounds may be used in combination with a chemotherapeutic agent and/or a potentiator.
    Type: Grant
    Filed: September 29, 2000
    Date of Patent: March 8, 2005
    Assignee: UAF Technologies and Research, LLC
    Inventors: James Berger Camden, James Clarence Quada, Jr., Joseph K. Agyin
  • Patent number: 6720349
    Abstract: Benzimidazole derivatives and salts and prodrugs thereof are disclosed, together with methods for the treatment of cancers or viral infections in warm blooded animals by administration of these compounds. Such compounds may be used in combination with a chemotherapeutic agent and/or a potentiator.
    Type: Grant
    Filed: April 25, 2002
    Date of Patent: April 13, 2004
    Assignee: UAF Technologies and Research, LLC
    Inventors: James C. Quada, Jr., Joseph K. Agyin, James Berger Camden
  • Patent number: 6710065
    Abstract: Benzimidazole derivatives and salts and prodrugs thereof are disclosed, together with methods for the treatment of cancers or viral infections in warm blooded animals by administration of these compounds. Such compounds may be used in combination with a chemotherapeutic agent and/or a potentiator.
    Type: Grant
    Filed: September 29, 2000
    Date of Patent: March 23, 2004
    Assignee: UAF Technologies and Research, LLC
    Inventors: James Berger Camden, Joseph K. Agyin, James C. Quada, Jr.